With a key interest in IBD, the ECCO Corporate Members follow the ECCO Statutes and ethical standards. Representatives of Corporate Members are invited to attend the General Assembly, but do not hold voting rights.
Corporate Members can benefit from a range of ECCO initiatives based on a commitment of at least 2 consecutive years.
ECCO gratefully acknowledges the support of the following corporate members in 2024:
ECCO offers sincere gratitude for support of Fellowships and Grants, encouraging young physicians in their careers and promoting innovative scientific research in IBD in Europe:
2023 ECCO N-ECCO Research Grant, ECCO D-ECCO Research Grant (supported by BMS)
2023 ECCO Basic Science Grant (supported by BMS)
2022 ECCO Basic Science Grant (supported by BMS)
2020 ECCO Multi-Year Research Grant (supported by Pfizer)
2018 ECCO-Pfizer Research Grant on Predictors of response to JAK inhibitors
2018 ECCO-Pfizer Research Award
2017 ECCO-Vifor Pharma Grant
2016 ECCO-Nestlé Health Science Nutrition Fellowship
2014 ECCO-DigestScience Research Funding
2014 Cosmopharma-funded ECCO Fellowship